Robert Gniadecki

Medicin og biovidenskab

1. Adalimumab 26%
2. Apoptosis 19%
3. Atopic Dermatitis 25%
4. AVX001 8%
5. Basal Cell Carcinoma 29%
6. Biological Factors 10%
7. Biological Products 11%
8. Cancer-Associated Fibroblasts 9%
9. Cell Line 8%
10. Cohort Studies 12%
11. Cutaneous Malignant Melanoma 10%
12. Cutaneous T-Cell Lymphoma 100%
13. Denmark 9%
14. Dermatology 14%
15. Electrons 10%
16. Etanercept 18%
17. Ficusin 12%
18. Hidradenitis Suppurativa 9%
19. Interleukin-17 9%
20. Keratinocytes 9%
21. Lymphoma 20%
22. Melanoma 22%
23. MicroRNAs 32%
24. Mohs Surgery 9%
25. Mycosis Fungoides 85%
26. Neoplasms 17%
27. Nevus 10%
28. nutlin 3 11%
29. Pharmaceutical Preparations 7%
30. Photopheresis 15%
31. Pigmented Nevus 9%
32. Primary Cutaneous Anaplastic Large Cell Lymphoma 13%
33. Psoriasis 95%
34. Psoriatic Arthritis 18%
35. Quality of Life 10%
36. Radiation 8%
37. Retrospective Studies 8%
38. Safety 11%
39. secukinumab 16%
40. Skin 46%
41. Skin Diseases 15%
42. Skin Neoplasms 11%
43. STAT3 Transcription Factor 8%
44. Survival 9%
45. T-Cell Antigen Receptor 16%
46. T-Cell Lymphoma 10%
47. T-Lymphocytes 26%
48. Therapeutics 21%
49. Ubiquitin-Specific Proteases 10%
50. Ustekinumab 19%